Study

Single Patient BRAF Mutant Brain Tumor, Pre- and Post-dabrafenib WES.

Study ID Alternative Stable ID Type
phs001629 Case Set

Study Description

A single adolescent patient with a BRAF V600E mutated brain tumor was treated with dabrafenib and had a complete response, followed by progression. The pre-treatment and post-progression tumors were both sequenced in order to identify potential drivers of resistance.

Archive Link Archive Accession
dbGaP phs001629

Who archives the data?

There are no publications available